These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33360232)

  • 1. Management of calcium pyrophosphate crystal deposition disease: A systematic review.
    Parperis K; Papachristodoulou E; Kakoullis L; Rosenthal AK
    Semin Arthritis Rheum; 2021 Feb; 51(1):84-94. PubMed ID: 33360232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium pyrophosphate deposition (CPPD) disease - Treatment options.
    Stack J; McCarthy G
    Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101720. PubMed ID: 34756508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the therapeutic management of calcium pyrophosphate deposition disease.
    Voulgari PV; Venetsanopoulou AI; Drosos AA
    Front Med (Lausanne); 2024; 11():1327715. PubMed ID: 38529115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.
    Whelan MG; Hayashi K; Altwies H; Tedeschi SK
    J Rheumatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 37061233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].
    Announ N; Guerne PA
    Z Rheumatol; 2007 Nov; 66(7):573-4, 576-8. PubMed ID: 17932681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on calcium pyrophosphate deposition.
    Abhishek A; Doherty M
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):32-8. PubMed ID: 27586801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy for CPPD: Options and Evidence.
    Andrés M; Sivera F; Pascual E
    Curr Rheumatol Rep; 2018 Apr; 20(6):31. PubMed ID: 29675606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium pyrophosphate dihydrate crystal induced arthropathy].
    Announ N; Guerne PA
    Rev Med Suisse; 2007 Mar; 3(103):740-2, 744, 746. PubMed ID: 17458152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy].
    Eliseev MS; Zheliabina OV; Kirillova IG; Korsakova YO
    Ter Arkh; 2023 Jul; 95(5):386-391. PubMed ID: 38158992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.
    Altomare A; Corrado A; Maruotti N; Cici D; Cantatore FP
    Mol Biol Rep; 2021 May; 48(5):4789-4796. PubMed ID: 34075537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cartilage icing and chondrocalcinosis on knee radiographs in the differentiation between gout and calcium pyrophosphate deposition.
    Falkowski AL; Jacobson JA; Kalia V; Meyer NB; Gandikota G; Yosef M; Thiele RG
    PLoS One; 2020; 15(4):e0231508. PubMed ID: 32298308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].
    Tausche AK; Aringer M
    Z Rheumatol; 2014 May; 73(4):349-57; quiz 358-9. PubMed ID: 24811359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-centre retrospective case series of Anakinra for incident calcium pyrophosphate deposition disease.
    Lian A; Shandilya A; Riordan J
    Clin Rheumatol; 2023 Jul; 42(7):1833-1837. PubMed ID: 36913030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.
    Finckh A; Mc Carthy GM; Madigan A; Van Linthoudt D; Weber M; Neto D; Rappoport G; Blumhardt S; Kyburz D; Guerne PA
    Arthritis Res Ther; 2014 Oct; 16(5):458. PubMed ID: 25315665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium pyrophosphate deposition disease: clinical manifestations.
    Ferrone C; Andracco R; Cimmino MA
    Reumatismo; 2012 Jan; 63(4):246-52. PubMed ID: 22303531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium crystal-associated arthritides.
    Rosenthal AK
    Curr Opin Rheumatol; 1998 May; 10(3):273-7. PubMed ID: 9608333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances in therapies for calcium pyrophosphate crystal arthritis.
    Sivera F; Andrés M; Pascual E
    Curr Opin Rheumatol; 2016 Mar; 28(2):140-4. PubMed ID: 26780424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of articular chondrocalcinosis--role of ANKH.
    Abhishek A; Doherty M
    Nat Rev Rheumatol; 2011 Feb; 7(2):96-104. PubMed ID: 21102543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Narrative Review of Chondrocalcinosis: Clinical Presentation, Diagnosis, and Therapies.
    Kim SY; Afroz S; Gillespie H; Downey C
    Cureus; 2024 May; 16(5):e60434. PubMed ID: 38882993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating CPPD crystal deposition, an important disease of aging.
    Bonafede RP
    Geriatrics; 1988 Nov; 43(11):59-64, 68. PubMed ID: 2846412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.